SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH M impact

Health Canada Approves Lilly’s Mounjaro to Reduce Cardiovascular Risk

Health Canada approved Lilly’s Mounjaro (tirzepatide) for reducing cardiovascular risk in adults with type 2 diabetes.

Related stories